These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 6132693

  • 1. Antiplatelet agents: rationale and results.
    Kelton JG.
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract] [Full Text] [Related]

  • 2. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE, Bergqvist D, Tangen O.
    Acta Chir Scand; 1975 Feb; 141(1):40-2. PubMed ID: 1092111
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Actions and clinical status of platelet-suppressive agents.
    Didisheim P, Fuster V.
    Semin Hematol; 1978 Jan; 15(1):55-72. PubMed ID: 341328
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Current clinical results of antiplatelet medication].
    Ordinas A.
    Sangre (Barc); 1984 Jan; 29(4-C):833-40. PubMed ID: 6393391
    [No Abstract] [Full Text] [Related]

  • 8. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE, Cortellaro M.
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract] [Full Text] [Related]

  • 9. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E.
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract] [Full Text] [Related]

  • 10. [Antiplatelet drugs (author's transl)].
    Dechavanne M, Follea G, Trzeciak MC.
    Anesth Analg (Paris); 1979 Dec; 36(7-8):283-7. PubMed ID: 525834
    [Abstract] [Full Text] [Related]

  • 11. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H, Avenarius HJ.
    Int Angiol; 1986 Dec; 5(3):169-80. PubMed ID: 2435823
    [Abstract] [Full Text] [Related]

  • 12. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS.
    Med J Aust; 1985 Jan 07; 142(1):41-7. PubMed ID: 3880861
    [Abstract] [Full Text] [Related]

  • 13. [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
    Bousser MG, Lecrubier C.
    Nouv Presse Med; 1973 Jun 23; 2(25):1687-92. PubMed ID: 4718537
    [No Abstract] [Full Text] [Related]

  • 14. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F.
    Union Med Can; 1976 Aug 23; 105(8):1159-73. PubMed ID: 10662
    [No Abstract] [Full Text] [Related]

  • 15. Platelet function inhibitors: their clinical use.
    Fuster V, Didisheim P.
    Adv Intern Med; 1978 Aug 23; 23():251-64. PubMed ID: 343540
    [No Abstract] [Full Text] [Related]

  • 16. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H.
    Acta Med Austriaca Suppl; 1982 Aug 23; 25():55-61. PubMed ID: 6958157
    [No Abstract] [Full Text] [Related]

  • 17. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O.
    Schweiz Med Wochenschr; 1979 Mar 10; 109(10):348-53. PubMed ID: 424707
    [Abstract] [Full Text] [Related]

  • 18. Management of thrombotic diseases.
    Douglas AS.
    Semin Hematol; 1971 Apr 10; 8(2):95-139. PubMed ID: 4396057
    [No Abstract] [Full Text] [Related]

  • 19. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA, Hirsh J, Gent M, Genton E.
    Prog Hematol; 1975 Apr 10; 9():229-54. PubMed ID: 766074
    [No Abstract] [Full Text] [Related]

  • 20. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M.
    Clin Ter; 1979 Oct 31; 91(2):117-27. PubMed ID: 396098
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.